欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0586/001
药品名称Bivalirudin Accord 250 mg powder for concentrate for solution for injection or infusion
活性成分
    • Bivalirudin 250.0 mg
剂型Powder for concentrate for solution for infusion/injection
上市许可持有人Accord Healthcare B.V. Winthontlaan 200, 3526KV Utrecht Niederlande ÜBER Accord Healthcare Lim., UK
参考成员国 - 产品名称Austria (AT)
Bivalirudin Accord 250 mg Pulver für ein Konzentrat zur Herstellung einer Injektions- oder Infusions
互认成员国 - 产品名称
    • Germany (DE)
      Bivalirudin Accord 250 mg Pulver z. H. e. Konz. f. e. Injektions - o. Infusionslösung
    • Belgium (BE)
      Bivalirudin Accord Healthcare 250 mg poeder voor concentraat voor oplossing voor injectie of intrave
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Poland (PL)
      Biwalirudyna Accord
    • Slovenia (SI)
      Bivalirudin Accord 250 mg prašek za koncentrat za raztopino za injiciranje ali infundiranje
许可日期2016/05/12
最近更新日期2024/11/25
药物ATC编码
    • B01AE06 bivalirudin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase